Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF INFORMATION ABOUT REPORTED SEGMENT PROFIT OR LOSS AND ASSETS (Details)

v3.22.1
SCHEDULE OF INFORMATION ABOUT REPORTED SEGMENT PROFIT OR LOSS AND ASSETS (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information [Line Items]    
Revenues $ 2,199 $ 5,031
Operating loss (4,117)  
Financing expenses, net (3,471)  
Share in losses of affiliated companies accounted for under equity method, net  
Net loss (7,588) $ (17,557)
Breast Cancer Test [Member]    
Segment Reporting Information [Line Items]    
Revenues  
Operating loss (1,107)  
Net loss (1,107)  
Alzheimer [Member]    
Segment Reporting Information [Line Items]    
Revenues  
Operating loss  
Net loss  
COVID-19 Testing [Member]    
Segment Reporting Information [Line Items]    
Revenues 2,199  
Operating loss (1,303)  
Net loss (1,303)  
Unallocated [Member]    
Segment Reporting Information [Line Items]    
Revenues  
Operating loss (1,707)  
Financing expenses, net (3,471)  
Share in losses of affiliated companies accounted for under equity method, net  
Net loss $ (5,178)